Search results

ANSTO's unique capabilities are being used to develop a quick analytical tool to determine the geographic origin of seafood and authenticates quality.

Three new federal grants were announced to support manufacturing and nuclear technologies.

The National Deuteration Facility is providing deuterated cholesterol, an essential ingredient in lipid nanoparticles for the delivery of vaccines using mRNA, to academic and industry partners.

During the scheduled shutdown of the OPAL multi-purpose reactor, an ANSTO engineering and project team has installed a new safety shutdown instrumentation and control system (I&C).

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program

The ARC Centre of Excellence (CoE) for Green Electrochemical Transformation of Carbon Dioxide, GETCO2, will support innovative approaches to carbon capture.

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

ANSTO experts in the measurement of radioactivity and its impacts on the marine environment presented at an IAEA training course for representatives from Pacific Island countries held in early December.

A team of scientists led by Monash University and the University of Melbourne in association with the Peter Doherty Institute for Infection and Immunity have made progress in clarifying the molecular interactions that underpin how our adaptive immune cells recognise SARS CoV-2, which causes COVID-19.

Don't miss latest nuclear science and technology news from ANSTO.

The first experimental evidence to validate a newly published universal law that provides insights into the complex energy states for liquids has been found using an advanced nuclear technique at ANSTO.

Research to characterise how radioactive contaminants impact the surrounding environment.

Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.

ANSTO hosted an international meeting of Expert and Policy group members for Generation IV Forum (GIF).

Today an international team has provided a molecular basis for strong immunity against COVID-19.